Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SUNNY BIODISCOVERY INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- YZF7QJ8S3RL3
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant):
Chronic wounds translate into daily suffering for 7 million elderly people in United States and Europe alone. Modern dressings, as used today, are insufficient for optimal treatment of these wounds because most often they do not include compounds actively promoting wound healing. Stimulation of angiogenesis (wound vascularization) is a key requirement and a logic therapeutic approach to chronic wound healing. However, wound dressings, which include proteinaceous angiostimulators, are disappointing, because these stimulators are highly labile and cannot be maintained in treatment sites at therapeutic levels. Here we propose to test for enhancement of wound healing a small and stable angiostimulatory and fibroblast stimulatory molecule isolated in our laboratory from a Chinese medicinal plant. Using planimetry and advanced histochemistry we will test the effect of this stimulator on the speed and completeness of wound closure and on the quality of the reepithelialized tissue in animal and chimera human skin models. Furthermore, we will determine the chemical structure of this molecule with NMR, mass spectrometry, elemental analysis and crystallography. Taken together, this project aims to provide the proof-of-principle that a small stable angiogenesis/fibroblast stimulator can significantly improve wound healing and lead to a novel, commercially viable therapy for the treatment of chronic wounds.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
7 SBIR/STTR records share this UEI (2000–2013). Reported award amounts total $1,519,526. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards